Reperfusion Injury Global Clinical Trials Review, H1, 2014

NEW YORK, Feb. 20, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Reperfusion Injury Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0910504/Reperfusion-Injury-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Reperfusion Injury Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Reperfusion Injury Global Clinical Trials Review, H1, 2014" provides data on the Reperfusion Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Reperfusion Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Reperfusion Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Reperfusion Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Reperfusion Injury to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Reperfusion Injury to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Reperfusion Injury 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Reperfusion Injury Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Reperfusion Injury 31
Aug 27, 2013: Congenia Announces Enrollment of First Healthy Volunteer in Phase 1 31
May 29, 2013: NeuroVive Provides Update On Ongoing Phase III Study Of CicloMulsion For Treatment Of Reperfusion Injury 31
Sep 02, 2008: Fibrex Medical Reports Positive Phase II Results for FX06 32
Nov 30, 2007: Fibrex Medical Completes Enrolment of Phase II Trial of Treatment for Reperfusion Injury in Myocardial Infarction 32
Oct 09, 2006: Fibrex Medical Initiates Phase II Trial of Treatment for Reperfusion Injury in Myocardial Infarction 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Ikaria Inc. 34
Clinical Trial Overview of Ikaria Inc. 34
Stealth Peptides Inc. 35
Clinical Trial Overview of Stealth Peptides Inc. 35
Medicure Inc. 36
Clinical Trial Overview of Medicure Inc. 36
Dompe S.p.A. 37
Clinical Trial Overview of Dompe S.p.A. 37
Proteo, Inc. 38
Clinical Trial Overview of Proteo, Inc. 38
NeuroVive Pharmaceutical AB 39
Clinical Trial Overview of NeuroVive Pharmaceutical AB 39
Mcguire Research Institute, Inc 40
Clinical Trial Overview of Mcguire Research Institute, Inc 40
Ischemix 41
Clinical Trial Overview of Ischemix 41
INO Therapeutics, LLC 42
Clinical Trial Overview of INO Therapeutics, LLC 42
Clinical Trial Overview of Top Institutes / Government 43
Radboud University 43
Clinical Trial Overview of Radboud University 43
Medical University of Vienna 44
Clinical Trial Overview of Medical University of Vienna 44
Xijing Hospital 45
Clinical Trial Overview of Xijing Hospital 45
RWTH Aachen University 46
Clinical Trial Overview of RWTH Aachen University 46
University of Oxford 47
Clinical Trial Overview of University of Oxford 47
Herlev Hospital 48
Clinical Trial Overview of Herlev Hospital 48
Samsung Medical Center 49
Clinical Trial Overview of Samsung Medical Center 49
University of Zurich 50
Clinical Trial Overview of University of Zurich 50
Ludwig-Maximilians-Universitat Munich 51
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 51
University College London 52
Clinical Trial Overview of University College London 52
Five Key Clinical Profiles 53
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Reperfusion Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Reperfusion Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Reperfusion Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Reperfusion Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Reperfusion Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Reperfusion Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Reperfusion Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Reperfusion Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Reperfusion Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Reperfusion Injury Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Reperfusion Injury Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Reperfusion Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Reperfusion Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Reperfusion Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Reperfusion Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Reperfusion Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Reperfusion Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Inc., 2014* 34
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stealth Peptides Inc., 2014* 35
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2014* 36
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Dompe S.p.A., 2014* 37
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Proteo, Inc., 2014* 38
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by NeuroVive Pharmaceutical AB, 2014* 39
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Mcguire Research Institute, Inc, 2014* 40
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ischemix, 2014* 41
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by INO Therapeutics, LLC, 2014* 42
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 43
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 44
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2014* 45
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by RWTH Aachen University, 2014* 46
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 47
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014* 48
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 49
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 50
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2014* 51
Reperfusion Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2014* 52

List of Figures

Reperfusion Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Reperfusion Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Reperfusion Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Reperfusion Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Reperfusion Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Reperfusion Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Reperfusion Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Reperfusion Injury to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Reperfusion Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Reperfusion Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Reperfusion Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Reperfusion Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Reperfusion Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Reperfusion Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Reperfusion Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Reperfusion Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Reperfusion Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 76

To order this report: Reperfusion Injury Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0910504/Reperfusion-Injury-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.